Fervent Synergies Intrinsic Value
Fervent Synergies (FERVENTSYN) median intrinsic value is ₹9.12 from 8 valuation models (range ₹5–₹14), vs current price ₹18.14 — -49.7% downside (Trading Above Calculated Value), margin of safety -98.9%. Browse FERVENTSYN complete financial statements for revenue, profit, balance sheet and cash flow data.
FERVENTSYN Valuation Methods Summary — DCF, Graham Number & P/E
Fervent Synergies intrinsic value across 8 models vs current price ₹18.14 — upside/downside and value range per method. For current market price and key ratios, visit Fervent Synergies share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹9.12 | ₹7.30 - ₹10.94 | -49.7% | EPS: ₹0.76, Sector P/E: 12x |
| Book Value Method | asset | ₹11.40 | ₹10.26 - ₹12.54 | -37.2% | Book Value/Share: ₹11.40, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹5.44 | ₹4.90 - ₹5.98 | -70.0% | Revenue/Share: ₹3.20, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹7.26 | ₹6.53 - ₹7.99 | -60.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹12.16 | ₹10.94 - ₹13.38 | -33.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹6.54 | ₹5.89 - ₹7.19 | -63.9% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹9.07 | ₹8.16 - ₹9.98 | -50.0% | ROE: 7.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹13.96 | ₹12.56 - ₹15.36 | -23.0% | EPS: ₹0.76, BVPS: ₹11.40 |
FERVENTSYN Intrinsic Value vs Market Price — All Valuation Models
Fervent Synergies fair value range ₹5–₹14 vs current market price ₹18.14 across 8 valuation models. Also explore FERVENTSYN share price charts to track price trends across different timeframes.
FERVENTSYN Intrinsic Value Analysis — Undervalued or Overvalued?
Fervent Synergies median intrinsic value ₹9.12, current price ₹18.14 — Trading Above Calculated Value by 49.7%, margin of safety -98.9%.
What is the intrinsic value of FERVENTSYN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Fervent Synergies (FERVENTSYN) is ₹9.12 (median value). With the current market price of ₹18.14, this represents a -49.7% variance from our estimated fair value.
The valuation range spans from ₹5.44 to ₹13.96, indicating ₹5.44 - ₹13.96.
Is FERVENTSYN undervalued or overvalued?
Based on our multi-method analysis, Fervent Synergies (FERVENTSYN) appears to be trading above calculated value by approximately 49.7%.
FERVENTSYN Financial Health — Key Ratios vs Industry Benchmarks
Fervent Synergies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 50.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 7.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 24.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.28x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
FERVENTSYN Cash Flow Quality — Operating & Free Cash Flow
Fervent Synergies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-15 Cr | ₹-15 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |